The page is the record's research on the issuer — no analyst, no rating, no view.

MABION (PLMBION00016) — research page

PL · pl-cm-kg/XWAR/PLMBION00016 · as of 2026-11-06

Identity and listing

The issuer is MABION, listed on the GPW Main Market under ticker PLMBION00016, with ISIN PLMBION00016 and LEI 259400KG5JVQPPZL6X53. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.

fieldvaluesource · read date
nameMABIONsource · 2026-11-06
exchangeGPW Main Marketsource · 2026-11-06
tickerPLMBION00016source · 2026-11-06
ISINPLMBION00016source · 2026-11-06
LEI259400KG5JVQPPZL6X53source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 46 filings in the twelve months to 2026-11-06, on 41 filing days. Of these, 42 are ESPI Current, 2 are ESPI Quarterly, 1 is ESPI half years and 1 is EBI Current. The median gap between filing days is 8.5 days. The latest filing is an ESPI Current dated 2026-11-04, 2 days before the record date. The GPW Main Market has 436 issuers with a median cadence gap of 8.0 days, a median of 31.0 filings and a median latency of 10 days. The sector peer figures are not on the record for this market.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer468.52
exchange median: GPW Main Market (436 issuers)31810
datetypecategoryfiling
2026-11-04ESPI CurrentESPI CurrentAmerykańska Agencja ds. Żywności i Leków (FDA) wspiera rejestrację MabionCD20 jako innowacyjnego leku biologicznego
2026-10-20ESPI CurrentESPI CurrentWażna aktualizacja dotycząca MabionCD20. Oddifact SAS ogłasza, że w wyniku konsultacji z amerykańską Agencją ds. Żywności i Leków (FDA) MabionCD20 może być stosowany jako terapia pierwszego rzutu, a czas trwania badania może zostać znacznie skrócony do za
2026-10-06ESPI CurrentESPI CurrentSpotkanie Pre-IND Typu B z amerykańską Agencją ds. Żywności i Leków (FDA) - kolejny kamień milowy na drodze do wprowadzenia MabionCD20 jako leku sierocego stosowanego w leczeniu immunologicznej trombocytopenii (ITP)
2026-10-01ESPI CurrentESPI CurrentRozszerzenie współpracy z WPD Pharmaceuticals S.A. - list intencyjny dotyczący wspólnej realizacji programu rozwoju biologicznych produktów leczniczych opartych na terapii celowanej w obszarze onkologii
2026-09-15ESPI CurrentESPI CurrentMabion S.A. zostanie poddany inspekcji amerykańskiej Agencji ds. Żywności i Leków (FDA)

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed, not halted.

Orderability

The outcome cannot be determined, because the chapter's orderability section carries no client categories. Rule version acm-68000/pl/mifid-ii-product-governance/r1 applies, with the chapter as of 2026-11-04.

rule acm-68000/pl/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 7 research houses: mBank, BM PKO BP, DM Trigon, Noble Securities, Ipopema Securities, BM Santander and Noble Securities S.A.

research houseanalystsource · read date
mBankBeata Szparaga-Waśniewskaissuer page · 2026-11-12
BM PKO BPDawid Górzyńskiissuer page · 2026-11-12
DM TrigonKatarzyna Kosiorekissuer page · 2026-11-12
Noble SecuritiesKrzysztof Radojewskiissuer page · 2026-11-12
Ipopema SecuritiesŁukasz Kosiarskiissuer page · 2026-11-12
BM SantanderTomasz Krukowskiissuer page · 2026-11-12
Noble Securities S.A.issuer page · 2026-11-12

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No years are sealed for this issuer, and the live record began on a date not on the record.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.pl-cm-kg.ai/events/XWAR/PLMBION00016 (the disclosure lines)
10.4
https://www.gpw.pl/zawieszenia-i-wykluczenia (the halt flag)
10.5
https://pl.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://www.mabion.eu/analysts/ (coverage)
10.7
https://mcp.pl-cm-kg.ai/record/XWAR/PLMBION00016 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"PLMBION00016"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:98691ed6d14542a4.